Table 4.
Univariate and multivariate Cox proportional hazard regression analysis for DM patients
| Clinical outcomes (n, %) | Univariate multivariate | |||
|---|---|---|---|---|
| HR (95% CI) | P | HR (95% CI) | P | |
| MACE | 1.245 (0.935–1.656) | 0.133 | 1.252 (0.939–1.669) | 0.126 |
| All-cause death | 0.986 (0.407–2.389) | 0.976 | 0.953 (0.387–2.351) | 0.917 |
| Cardiac death | 0.555 (0.128–2.412) | 0.432 | 0.410 (0.089–1.879) | 0.251 |
| Non-fatal MI | 1.808 (0.992–3.295) | 0.053 | 1.689 (0.913–3.122) | 0.095 |
| Stent thrombosis | 1.116 (0.419–2.974) | 0.826 | 1.002 (0.370–2.714) | 0.997 |
| Revascularization | 1.205 (0.846–1.717) | 0.300 | 1.215 (0.852–1.733) | 0.283 |
| TVR | 1.329 (0.843–2.096) | 0.221 | 1.325 (0.835–2.101) | 0.232 |
| TLR | 1.495 (0.923–2.422) | 0.103 | 1.453 (0.891–2.371) | 0.134 |
| Stroke | 0.681 (0.237–1.950) | 0.474 | 0.731 (0.253–2.111) | 0.563 |
| Bleeding | 0.748 (0.471–1.188) | 0.219 | 0.727 (0.447–1.182) | 0.198 |
| BRAC 2_5 | 0.710 (0.337–1.497) | 0.368 | 0.705 (0.333–1.491) | 0.360 |
| BRAC 3_5 | 0.554 (0.069–4.432) | 0.578 | 0.563 (0.070–4.535) | 0.590 |
DM diabetes mellitus, G2-DES second generation drug-eluting stent, BP-DES biodegradable polymer drug-eluting stent, MACE major adverse cardiac events, MI myocardial infarction, TVR target vessel revascularization, BARC Bleeding Academic Research Consortium definition